Literature DB >> 14064818

A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

K BERG.   

Abstract

Entities:  

Keywords:  BLOOD GROUPS; BLOOD PROTEINS; GEL DIFFUSION TESTS; IMMUNE SERUMS; IMMUNOELECTROPHORESIS; LIPOPROTEINS; PRECIPITIN TESTS; RABBITS

Mesh：

Substances：

Year:  1963        PMID： 14064818     DOI： 10.1111/j.1699-0463.1963.tb01808.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN： 0365-5555


× No keyword cloud information.
  193 in total

1.  An application of apo(a) isoforms for the clinical assessment of Lp(a).

Authors:  S Takayama; Y Yasumuro; J h Kim; M Ishikawa; D Tsujino; S Matsuo; Y Harada; S Sugii
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Lipoprotein(a) and coronary heart disease risk.

Authors:  S M Marcovina; R A Hegele; M L Koschinsky
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

3.  [THE LP-SYSTEM. PREPARATION OF THE ANTISERUM, TESTING METHODS, RESULTS].

Authors:  K BERG; G G WENDT
Journal:  Humangenetik       Date:  1964

Review 4.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

5.  Studies on the late-pre-beta-lipoprotein of human serum.

Authors:  I C Ononogbu
Journal:  Experientia       Date:  1979-09-15

6.  Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.

Authors:  Beate R Jaeger; Yvonne Richter; Dorothea Nagel; Franz Heigl; Anja Vogt; Eberhard Roeseler; Klaus Parhofer; Wolfgang Ramlow; Michael Koch; Gerd Utermann; Carlos A Labarrere; Dietrich Seidel
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

7.  Isolation and characterization of lipoprotein B from high-density human serum lipoproteins.

Authors:  G Kostner
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

Review 8.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 9.  Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.

Authors:  Adam N Berman; Ron Blankstein
Journal:  Curr Cardiol Rep       Date:  2019-08-05       Impact factor: 2.931

10.  Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout.

Authors:  S Takahashi; T Yamamoto; Y Moriwaki; Z Tsutsumi; K Higashino
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.